Structured research across four scientific domains
A Research & Development programme is a structured, systematic initiative to acquire new knowledge and develop innovative therapies. Champions applies this methodology across oncology, regenerative medicine, haematology and global-health policy — each involving genuine technical uncertainty and reproducible investigation.
Oncology & Cancer Therapeutics
Our primary R&D domain — tumour microenvironment dynamics, next-generation treatment strategies, and novel pharmacotherapy across haematological and solid malignancies.
Regenerative Medicine
Translational research into mesenchymal and haematopoietic stem-cell applications, tissue repair and cellular engineering platforms.
Haematology
Sickle cell disease management, gene-editing strategies and disease-modifying pharmacotherapy bridging symptom management and functional cure.
Global Health & Policy
Regulatory science, healthcare-infrastructure analysis and evidence-based policy frameworks addressing therapeutic access in Nigeria and emerging markets.
Active research programmes
Peer-reviewed evidence syntheses and translational reviews — for research and informational purposes, grounded in reproducible scientific evidence.
Advanced Stem Cell Research & Treatment Pathways
Mesenchymal and haematopoietic stem-cell applications in oncology and regenerative medicine.
Read study
Scorpion Venom — Oncology Research Compound
Bioactive peptides and Chlorotoxin (Tumor Paint) in cancer-selective therapeutics.
Read study
Sickle Cell: From Management to Functional Cure
Gene editing, stem-cell transplantation and disease-modifying pharmacotherapy.
Read study
Bioactive Peptide Therapeutics Research Initiative
Clinical potential, safety and translational applications of bioactive peptide compounds.
Read study
Phytocannabinoids in Traditional Nigerian Medicine
Scientific validation of phytocannabinoids and indigenous medicine within regulatory frameworks.
Read study
Border Securitization & Social Construction
Interdisciplinary analysis of contemporary border fortification and territorial governance.
Read studyWhy structured R&D matters
For Champions Pharmaceuticals, structured R&D is the engine that drives our mission — advancing innovative therapies in oncology, regenerative medicine and haematologic disease, with a specific commitment to closing treatment gaps for underserved populations in Nigeria and across Africa.